We source our Mesenchymal Stem Cells (MSC's) from the Wharton's Jelly of the ubilical cord that is harvested after a healthy live  birth.  Mesynchymal Stem Cells are most plentiful in this tissue and screened extensively for your safety.  Umbilical cord matrix (Wharton’s Jelly) is by far the best source of MSC’s. This cellular tissue not only contains all essential components for tissue engineering but is a rich source of young MSC’s.

The FDA identified “Umbilical Cord Tissue” as a “structural tissue” and states that structural tissue, in addition to cytokines and other factors, can and may have live cells present.   

The products we use are minimally manipulated human tissue allografts, regulated by the Food and Drug Administration (FDA) under 21 CFR Part 1271, section 361 as HCT/Ps (Human Cells, Tissues, and Cellular or Tissue-Based Products).

THE PRODUCT WE USE IS REGISTERED WITH THE FDA AND IS FULLY COMPLIANT WITH ALL REGULATIONS OF SECTION 361 HCT/P’s OF THE FDA

Unlike many practitioners who perform ‘blind’ injections and don’t use an imaging modality to accurately identify the damaged areas and place the product accordingly, at Capital City Regenerative Medicine we use a 100% safe imaging modality to optimize our results.

As part of your examination prior to your musculoskeletal or joint injection, a diagnostic musculoskeletal (MSK) ultrasound is performed to determine the current state of the injured area and to identify the specific location of the injection. The ultrasound exam provides real-time imaging that can evaluate the health/injury of tendons, muscle, ligaments, bone, cartilage, and bursa.

The exam consists of an ultrasound water-based gel, as a coupling agent, and an ultrasound probe for imaging the internal structures. The practitioner will place the probe over the injured area to expertly guide the injection to the musculoskeletal tissue. A specific protocol will be followed for your area of concern.